Theragnostic Technologies. a pre-clinical stage biotech company that is leveraging its proprietary nano-based carrier platforms to develop solutions for diagnostic, therapeutic & regenerative medicine.  Founded in 2012, it is a participant of StartUp NY, NIH Commercialization Accelerator Program (NIH-CAP), and situated at the Long Island High Technology Incubator on the campuses of Stony Brook University.